InnovAge
INNV
#5719
Rank
NZ$2.28 B
Marketcap
NZ$16.74
Share price
2.81%
Change (1 day)
79.09%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2026 (TTM): NZ$22.37 Million

According to InnovAge's latest financial reports the company's current earnings are NZ$1.01 Billion. In 2025 the company made an earning of NZ$9.33 Million, an increase over its 2024 earnings that were of -NZ$47.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$22.37 M139.59%
2025 NZ$9.33 M-119.56%
2024 -NZ$47.75 Million-24.58%
2023 -NZ$63.3 Million-31.82%
2022 -NZ$92.85 Million-681.94%
2021 NZ$15.95 M-388.91%
2020 -NZ$5.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$12.28 B 54,174.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-NZ$18.49 Million-181.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$18.81 Million-183.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.93 B 4,037.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland